Smartkarma AI, Smartkarma

αSK

Smartkarma AI

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

<ul>
  <li>Sunmax is a niche leader in collagen-based dermal fillers, capitalizing on a rapidly growing global medical aesthetics market driven by non-invasive procedures.</li>
  <li>The company exhibits a strong growth trajectory, evidenced by impressive multi-year CAGRs in revenue and net income, supported by high resilience and profitability metrics.</li>
  <li>Future growth is contingent on successful capacity expansion, with a new facility expected to be fully operational by H1 2027, and continued geographic expansion beyond its core markets in Taiwan and China.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  Sunmax is a niche leader in collagen-based dermal fillers, capitalizing on a rapidly growing global medical aesthetics market driven by non-invasive procedures.
  The company exhibits a strong growth trajectory, evidenced by impressive multi-year CAGRs in revenue and net income, supported by high resilience and profitability metrics.
  Future growth is contingent on successful capacity expansion, with a new facility expected to be fully operational by H1 2027, and continued geographic expansion beyond its core markets in Taiwan and China.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Sunmax Biotechnology (4728 TT) - Oct 2025

Taiwan

SunMax Biotechnology Co Ltd. is a medical device company dedicated to the development, manufacturing and commercialization of bio-surgical products. The Company specializes in the production of medical grade porcine collagen that is used in medical applications and biochemistry research.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Sunmax Biotechnology (4728 TT) - Oct 2025

Sunmax is a niche leader in collagen-based dermal fillers, capitalizing on a rapidly growing global medical aesthetics market driven by...

αSK